Comparative efficacy of cabozantinib and ramucirumab after sorafenib for patients with advanced hepatocellular carcinoma and AFP ≥ 400 ng/ml
暂无分享,去创建一个
B. Daniele | F. Piscaglia | D. Sarker | P. Mollon | M. Venerito | H. Lim | F. Marteau | Q. Xu | Joerg Trojan | Y. Li | R. Zaucher | R. K. Kelley